{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada (RMTC) est un journal scientifique bilingue révisé par les pairs et en accès libre en ligne publié par l’Agence de la santé publique du Canada (ASPC). Il fournit de l’information opportune et pratique sur les maladies infectieuses aux cliniciens, aux professionnels de la santé publique et aux responsables des politiques qui éclaire les politiques, le développement des programmes et les pratiques.\r\n","en":"The Canada Communicable Disease Report (CCDR) is a bilingual, peer-reviewed, open-access, online scientific journal published by the Public Health Agency of Canada (PHAC). It provides timely, authoritative and practical information on infectious diseases to clinicians, public health professionals, and policy-makers to inform policy, program development and practice.\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"7e8140e9-feb6-4ece-b6ee-59927003aece","metadata_created":"2018-11-29T20:42:33.373774","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2018-11-29T20:42:33.373784","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2018-11-29","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["candida auris","pharmacorésistantes","infection","La résistance aux antituberculeux","pathogènes","toxines","Escherichia coli","Shiga-toxines"],"en":["Candida Auris","drug-resistant bacteria","Infection","prevention","tuberculosis","drug resistance","human pathogen","shiga toxin","Escherichia coli"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC: Volume 44-11, le 1er novembre 2018 : Infections liées aux soins de santé et résistance aux antimicrobiens","en":"CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a40f60e2-de5a-4839-887d-5af869b146c5","related_relationship":"","name_translated":{"fr":"RMTC : Volume 44-11, le 1er novembre 2018 : Infections liées aux soins de santé et résistance aux antimicrobiens","en":"CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance","language":["en"],"created":"2018-11-29T20:42:34.157234","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/ccdrv44i11-eng.pdf","last_modified":null,"position":0,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ae4f36d0-0b74-44b6-a2d5-319f8b0d8211","related_relationship":"","name_translated":{"fr":"RMTC : Volume 44-11, le 1er novembre 2018 : Infections liées aux soins de santé et résistance aux antimicrobiens","en":"CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance","language":["fr"],"created":"2018-11-29T20:42:34.157241","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/ccdrv44i11f-fra.pdf","last_modified":null,"position":1,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cfdb94dd-da72-4ac4-b47a-b47cabeb09e1","related_relationship":"","name_translated":{"fr":"Un micro-organisme redoutable à nos portes : Ce que les fournisseurs de soins de santé doivent savoir au sujet de Candida auris","en":"Something wicked this way comes: What health care providers need to know about Candida auris"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Something wicked this way comes: What health care providers need to know about Candida auris","language":["en"],"created":"2018-11-29T20:42:34.157244","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/article-1-candida-auris-management.html","last_modified":null,"position":2,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c27cf8ca-e91d-42a7-8764-2cca9bd2df23","related_relationship":"","name_translated":{"fr":"Un micro-organisme redoutable à nos portes : Ce que les fournisseurs de soins de santé doivent savoir au sujet de Candida auris","en":"Something wicked this way comes: What health care providers need to know about Candida auris"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Something wicked this way comes: What health care providers need to know about Candida auris","language":["fr"],"created":"2018-11-29T20:42:34.157247","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-11-1-novembre-2018/article-1-gestion-candida-auris.html","last_modified":null,"position":3,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"22d24163-eaa8-44c6-acb1-049110228fb4","related_relationship":"","name_translated":{"fr":"Rapporter des souvenirs importuns : les voyages et les bactéries pharmacorésistantes","en":"Bringing home unwelcome souvenirs: Travel and drug-resistant bacteria"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Bringing home unwelcome souvenirs: Travel and drug-resistant bacteria","language":["en"],"created":"2018-11-29T20:42:34.157249","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/article-2-travel-drug-resistant-bacteria.html","last_modified":null,"position":4,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"88d2ae73-dcc4-4c99-a8f1-8394641291a9","related_relationship":"","name_translated":{"fr":"Rapporter des souvenirs importuns : les voyages et les bactéries pharmacorésistantes","en":"Bringing home unwelcome souvenirs: Travel and drug-resistant bacteria"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Bringing home unwelcome souvenirs: Travel and drug-resistant bacteria","language":["fr"],"created":"2018-11-29T20:42:34.157251","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-11-1-novembre-2018/article-2-voyages-bacteries-pharmacoresistantes.html","last_modified":null,"position":5,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"221308f2-6951-4f79-93c6-4c796ad1855d","related_relationship":"","name_translated":{"fr":"Le Comité consultatif national sur la prévention et le contrôle des infections (CCN-PCI) au Canada","en":"The National Advisory Committee on Infection Prevention and Control (NAC-IPC)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The National Advisory Committee on Infection Prevention and Control (NAC-IPC)","language":["en"],"created":"2018-11-29T20:42:34.157254","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/article-3-introducing-national-advisory-committee-infection-prevention-control.html","last_modified":null,"position":6,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7a60dd9c-b9f2-4f1f-9e81-c2787d18a4bf","related_relationship":"","name_translated":{"fr":"Le Comité consultatif national sur la prévention et le contrôle des infections (CCN-PCI) au Canada","en":"The National Advisory Committee on Infection Prevention and Control (NAC-IPC)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The National Advisory Committee on Infection Prevention and Control (NAC-IPC)","language":["fr"],"created":"2018-11-29T20:42:34.157256","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-11-1-novembre-2018/article-3-introduction-comite-consultatif-national-prevention-controle-des-infections.html","last_modified":null,"position":7,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a753a21d-65d6-480d-a3bf-1ddfe1072930","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada : 2017","en":"Tuberculosis drug resistance in Canada: 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada: 2017","language":["en"],"created":"2018-11-29T20:42:34.157258","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/article-4-tb-drug-resistance-2017.html","last_modified":null,"position":8,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"22e6da63-c8a0-4ff0-8d58-32b6de960d2a","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada : 2017","en":"Tuberculosis drug resistance in Canada: 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada: 2017","language":["fr"],"created":"2018-11-29T20:42:34.157260","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-11-1-novembre-2018/article-4-resistance-antituberculeux-2017.html","last_modified":null,"position":9,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"456411cf-d125-4169-9ab2-269b8f1a5bec","related_relationship":"","name_translated":{"fr":"Surveillance des expositions en laboratoire aux agents pathogènes humains et aux toxines au Canada en 2017","en":"Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017","language":["en"],"created":"2018-11-29T20:42:34.157263","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/article-5-laboratory-exposures-human-pathogens-toxins-canada-2017.html","last_modified":null,"position":10,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"33d10a1f-1113-433e-936b-89fba73fa0c6","related_relationship":"","name_translated":{"fr":"Surveillance des expositions en laboratoire aux agents pathogènes humains et aux toxines au Canada en 2017","en":"Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017","language":["fr"],"created":"2018-11-29T20:42:34.157265","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-11-1-novembre-2018/article-5-exposition-laboratoire-pathogenes-humains-toxines-canada-2017.html","last_modified":null,"position":11,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"02db56ac-2f06-43a4-81f0-bc9a7e5b7243","related_relationship":"","name_translated":{"fr":"Recommandations du Réseau des laboratoires de santé publique du Canada (RLSPC) pour la détection en laboratoire d’Escherichia coli producteurs de Shiga-toxines (O157 et non-O157)","en":"CPHLN recommendations for the laboratory detection of Shiga toxin-producing Escherichia coli (O157 and non-O157)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPHLN recommendations for the laboratory detection of Shiga toxin-producing Escherichia coli (O157 and non-O157)","language":["en"],"created":"2018-11-29T20:42:34.157267","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/article-6-detecting-ecoli-o157-non-o157.html","last_modified":null,"position":12,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a14298b2-e3b0-4c69-a541-4bdec6c7ace2","related_relationship":"","name_translated":{"fr":"Recommandations du Réseau des laboratoires de santé publique du Canada (RLSPC) pour la détection en laboratoire d’Escherichia coli producteurs de Shiga-toxines (O157 et non-O157)","en":"CPHLN recommendations for the laboratory detection of Shiga toxin-producing Escherichia coli (O157 and non-O157)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPHLN recommendations for the laboratory detection of Shiga toxin-producing Escherichia coli (O157 and non-O157)","language":["fr"],"created":"2018-11-29T20:42:34.157269","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-11-1-novembre-2018/article-6-detection-ecoli-o157-non-o157.html","last_modified":null,"position":13,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5d7594bd-9787-45eb-bd28-9dbd6ccf28a4","related_relationship":"","name_translated":{"fr":"Correction des auteurs au Relevé des maladies transmissible au Canada 2018;44(10)","en":"Authors’ correction: Can Commun Dis Rep 2018;44(10)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Authors’ correction: Can Commun Dis Rep 2018;44(10)","language":["en"],"created":"2018-11-29T20:42:34.157271","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-11-november-1-2018/article-7-ccdr-corrections-44-10.html","last_modified":null,"position":14,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7e8140e9-feb6-4ece-b6ee-59927003aece","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f24d31eb-4a97-4c38-80f3-44e8ff8fbd06","related_relationship":"","name_translated":{"fr":"Correction des auteurs au Relevé des maladies transmissible au Canada 2018;44(10)","en":"Authors’ correction: Can Commun Dis Rep 2018;44(10)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Authors’ correction: Can Commun Dis Rep 2018;44(10)","language":["fr"],"created":"2018-11-29T20:42:34.157273","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-11-1-novembre-2018/article-7-corrections-rmtc-44-10.html","last_modified":null,"position":15,"revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded","resource_type":"publication"}],"place_of_publication":[],"num_resources":16,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2018-11-01 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"7e8140e9-feb6-4ece-b6ee-59927003aece","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report (CCDR) is a bilingual, peer-reviewed, open-access, online scientific journal published by the Public Health Agency of Canada (PHAC). It provides timely, authoritative and practical information on infectious diseases to clinicians, public health professionals, and policy-makers to inform policy, program development and practice.\r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":["educators","general_public","government","scientists","students"],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance","revision_id":"8ddaf4df-8893-4468-ac7b-0ebced941ded"}